Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENBALV trial of edoxaban versus warfarin after surgical bioprosthetic valve replacement
jRCT2051210209Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Cardiac valve disease (VHD) comparing Edoxaban arm with Warfarin arm (2 arms). Primary endpoint: Occurrence rate of stroke or systemic embolism. Started Apr 2022; status: completed.
02
Drugs
edoxabanwarfarin
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on jRCT2051210209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051210209.